Sale!

TFAP2A Gene Branchiooculofacial Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TFAP2A Gene Branchiooculofacial Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TFAP2A gene, which are associated with Branchiooculofacial Syndrome (BOFS). This condition is a rare genetic disorder characterized by distinctive facial features, skin anomalies, and defects in the structure of the ears, eyes, and throat. The test plays a crucial role in the early diagnosis and management of BOFS, allowing for personalized treatment plans and genetic counseling for affected families. Priced at 4400 AED, the test offers a comprehensive analysis of the TFAP2A gene, providing insights into the genetic underpinnings of BOFS and facilitating a better understanding of the condition’s inheritance patterns. DNA Labs UAE utilizes state-of-the-art genetic sequencing technologies to ensure accurate and reliable results, making it a valuable resource for patients and healthcare providers dealing with Branchiooculofacial Syndrome.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TFAP2A Gene Branchiooculofacial syndrome Genetic Test

Cost: AED 4400.0

Symptoms and Diagnosis

The TFAP2A gene is associated with a rare genetic disorder called Branchiooculofacial syndrome (BOFS). BOFS is characterized by specific facial features, abnormalities of the eyes, ears, and branchial arches, and sometimes intellectual disability.

Test Components

  • NGS Technology
  • Dysmorphology Test Type
  • Genetics Test Department

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Doctor

Pediatrics

Pre Test Information

A Genetic Counselling session to draw a pedigree chart of family members affected with TFAP2A Gene Branchiooculofacial syndrome NGS Genetic DNA Test gene TFAP2A

Test Details

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of BOFS, NGS genetic testing can be used to identify mutations or variations in the TFAP2A gene that may be responsible for causing the syndrome. By analyzing the entire coding region of the TFAP2A gene, NGS testing can provide a comprehensive and accurate assessment of any genetic changes that may be present. This can help in confirming a diagnosis of BOFS and providing valuable information for genetic counseling and management of the condition.

It is important to note that NGS genetic testing for BOFS may not be available in all healthcare settings and may require consultation with a geneticist or genetic counselor. Additionally, the results of genetic testing should always be interpreted in conjunction with other clinical findings and family history to ensure accurate diagnosis and appropriate management.

Test Name TFAP2A Gene Branchiooculofacial syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TFAP2A Gene Branchiooculofacial syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TFAP2A Gene Branchiooculofacial syndrome NGS Genetic DNA Test gene TFAP2A
Test Details

The TFAP2A gene is associated with a condition called Branchiooculofacial syndrome (BOFS). BOFS is a rare genetic disorder characterized by specific facial features, abnormalities of the eyes, ears, and branchial arches, and sometimes intellectual disability.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of BOFS, NGS genetic testing can be used to identify mutations or variations in the TFAP2A gene that may be responsible for causing the syndrome.

By analyzing the entire coding region of the TFAP2A gene, NGS testing can provide a comprehensive and accurate assessment of any genetic changes that may be present. This can help in confirming a diagnosis of BOFS and providing valuable information for genetic counseling and management of the condition.

It is important to note that NGS genetic testing for BOFS may not be available in all healthcare settings and may require consultation with a geneticist or genetic counselor. Additionally, the results of genetic testing should always be interpreted in conjunction with other clinical findings and family history to ensure accurate diagnosis and appropriate management.